University of North Dakota

UND Research Team to Evaluate VR Therapy for Pediatric Amblyopia in NIH-Funded Clinical Trials

• The University of North Dakota (UND) research team has been approved to conduct clinical trials for the Pediatric Eye Disease Group (PEDIG), focusing on innovative treatments for childhood eye conditions. • The trials will assess the effectiveness of virtual reality (VR) headsets as a novel approach to treating amblyopia, also known as lazy eye, in children aged 4 to 12. • These PEDIG studies, funded by the National Eye Institute (NEI) and the National Institutes of Health (NIH), aim to compare VR therapy with traditional eye patching for amblyopia treatment. • The research could potentially change the standard of care for amblyopia, offering a more engaging and effective alternative to conventional methods.